Last reviewed · How we verify
NCT04127253
Evaluation of the Hypoalgesic Effects of Transcranial Direct Current (tDCS) in Healthy Subjects
NA trial testing Sooma transcranial direct current stimulation device plus Brain training tools in Pain Modulation in 45 participants. Status unknown.
1 June 2020
Quick facts
| Lead sponsor | Universidad Autonoma de Madrid |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | basic science |
| Enrollment | 45 |
| Start date | 1 January 2020 |
| Primary completion | 1 June 2020 |
| Estimated completion | 1 July 2020 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Sooma transcranial direct current stimulation device plus Brain training tools
- Placebo Sooma transcranial direct current stimulation deviceplus Brain training tools
- Brain training tools in isolation
Conditions studied
- Pain Modulation — all drugs for Pain Modulation →
Sponsor
Universidad Autonoma de Madrid — full company profile →
Who can join
Adults 18 to 65, any sex, with Pain Modulation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main objective of this research is to evaluate and quantify hypoalgesic effects caused by imagination and observation with or without the presence of transcranial direct current (tDCS) in healthy participants. The secondary objective of this research is to evaluate the possible relationships between hypoalgesic effects and different physical and cognitive variables such as the ability to generate motor mental images, mental chronometry and levels of physical activity.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04127253
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pain Modulation
Currently open trials in the same condition.
- NCT07247721 — Transcutaneous vs Percutaneous Electrical Stimulation of the Radial Nerve · NA · active not recruiting
Other Universidad Autonoma de Madrid trials
Trials by the same sponsor.
- NCT07090434 — Effect of Bei App for Fibromyalgia · NA · not yet recruiting
- NCT06726447 — Artificial Intelligence Satisfaction in Professionals and Patients · NA · recruiting
- NCT06601478 — Development and Implementation of a Tool for the Evaluation and Monitoring of the Mediterranean Lifestyle in the Clinica · NA · recruiting
- NCT05623579 — Education on BDNF on Pain Levels · NA · unknown
- NCT05736172 — 3h of PNE on BDNF and Pain Levels · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04127253 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Autonoma de Madrid
- Last refreshed: 15 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04127253.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing